136 related articles for article (PubMed ID: 12468014)
21. Present and future capabilities of molecular imaging techniques to understand brain function.
Jones T
J Psychopharmacol; 1999 Dec; 13(4):324-9. PubMed ID: 10667607
[TBL] [Abstract][Full Text] [Related]
22. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
23. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
24. PET physiological measurements using constant infusion.
Carson RE
Nucl Med Biol; 2000 Oct; 27(7):657-60. PubMed ID: 11091108
[TBL] [Abstract][Full Text] [Related]
25. In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits.
Ye XX; Hwang JJ; Hsieh JF; Chen JC; Chou YT; Tu KY; Wey SP; Ting G
Nucl Med Biol; 2004 Nov; 31(8):995-1003. PubMed ID: 15607481
[TBL] [Abstract][Full Text] [Related]
26. Measuring drug-related receptor occupancy with positron emission tomography.
Passchier J; Gee A; Willemsen A; Vaalburg W; van Waarde A
Methods; 2002 Jul; 27(3):278-86. PubMed ID: 12183116
[TBL] [Abstract][Full Text] [Related]
27. Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand.
Arakawa Y; Nai Y; Shidahara M; Furumoto S; Seki C; Okamura N; Tashiro M; Kudo Y; Yanai K; Gonda K; Watabe H
J Nucl Med; 2017 Aug; 58(8):1285-1292. PubMed ID: 28062596
[TBL] [Abstract][Full Text] [Related]
28. Simplifications in analyzing positron emission tomography data: effects on outcome measures.
Logan J; Alexoff D; Kriplani A
Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027
[TBL] [Abstract][Full Text] [Related]
29. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
[TBL] [Abstract][Full Text] [Related]
30. A standardized blood sampling scheme in quantitative FDG-PET studies.
Bentourkia M; Bol A; Ivanoiu A; Michel C; Coppens A; Sibomana M; Cosnard G; De Volder AG
IEEE Trans Med Imaging; 1999 May; 18(5):379-84. PubMed ID: 10416799
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic analysis of plasma curves obtained after i.v. injection of the PET radioligand [11C] raclopride provides a likely explanation for rapid radioligand metabolism.
Sestini S; Halldin C; Mansi L; Castagnoli A; Farde L
J Cell Physiol; 2012 Apr; 227(4):1663-9. PubMed ID: 21678422
[TBL] [Abstract][Full Text] [Related]
32. Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers.
Kågedal M; Cselényi Z; Nyberg S; Jönsson S; Raboisson P; Stenkrona P; Hooker AC; Karlsson MO
Neuroimage; 2012 Jul; 61(4):849-56. PubMed ID: 22425672
[TBL] [Abstract][Full Text] [Related]
33. A computer simulation study on the input function sampling schedules in tracer kinetic modeling with positron emission tomography (PET).
Feng D; Wang X; Yan H
Comput Methods Programs Biomed; 1994 Nov; 45(3):175-86. PubMed ID: 7705075
[TBL] [Abstract][Full Text] [Related]
34. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers.
Slifstein M; Laruelle M
Nucl Med Biol; 2001 Jul; 28(5):595-608. PubMed ID: 11516703
[TBL] [Abstract][Full Text] [Related]
35. Blood sampling devices and measurements.
Eriksson L; Kanno I
Med Prog Technol; 1991; 17(3-4):249-57. PubMed ID: 1839858
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography.
Hutchinson OC; Collingridge DR; Barthel H; Price PM; Aboagye EO
Curr Pharm Des; 2003; 9(11):917-29. PubMed ID: 12678875
[TBL] [Abstract][Full Text] [Related]
37. Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.
Luurtsema G; Verbeek GL; Lubberink M; Lammertsma AA; Dierckx R; Elsinga P; Windhorst AD; van Waarde A
Curr Top Med Chem; 2010; 10(17):1820-33. PubMed ID: 20645915
[TBL] [Abstract][Full Text] [Related]
38. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
39. Quantification of 11C-Laniquidar Kinetics in the Brain.
Froklage FE; Boellaard R; Bakker E; Hendrikse NH; Reijneveld JC; Schuit RC; Windhorst AD; Schober P; van Berckel BN; Lammertsma AA; Postnov A
J Nucl Med; 2015 Nov; 56(11):1730-5. PubMed ID: 26294297
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.
Huang Y; Hwang DR; Narendran R; Sudo Y; Chatterjee R; Bae SA; Mawlawi O; Kegeles LS; Wilson AA; Kung HF; Laruelle M
J Cereb Blood Flow Metab; 2002 Nov; 22(11):1377-98. PubMed ID: 12439295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
